Mount Sinai PRIME
Lake Success, New York, United States
Home health care service in New York City, New York
5 East 98th Street 4th Floor, New York, NY 10029
About Mount Sinai PRIME
"As part of the comprehensive spinal cord treatment services offered by the Spine Hospital at Mount Sinai, the Spine Center is a dedicated space within the hospital. The Spine Center is fully staffed with unparalleled experts—orthopedists, chiropractors, physiatrists, occupational therapists, physical therapists, social workers, nurse managers, and spine surgeons—each specializing in the care of patients receiving treatment for spinal disorders, including lumbar, cervical, spinal deformity, spine trauma, and athletic spine injuries."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mount Sinai PRIME
During the past decade, Mount Sinai PRIME conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer
2018-09-14
2022-05-13
Completed
155
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
2019-04-16
2023-02-17
Terminated
168
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
2021-06-02
2026-06-01
Recruiting
87
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
2021-02-18
2025-12-01
Recruiting
480
A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
2020-08-19
2025-11-30
Recruiting
110
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
2022-11-01
2027-05-01
Not yet recruiting
1,164
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai PRIME"
#1 collaborator was "Gynecologic Oncology Group" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Mount Sinai PRIME
According to Clinical.Site data, the most researched conditions in "Mount Sinai PRIME" are
"Allogeneic Hematopoietic Stem Cell Transplantation" (1 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Colitis, Ulcerative" (1 trials), "Fallopian Tube Adenocarcinoma" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Mount Sinai PRIME" in a lesser frequency.
Clinical Trials Intervention Types at Mount Sinai PRIME
Most popular intervention types in "Mount Sinai PRIME" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Vedolizumab" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials), "Azilsartan Medoxomil High-dose" (1 trials) and "Azilsartan Medoxomil Low-dose" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Sinai PRIME
The vast majority of trials in "Mount Sinai PRIME" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Mount Sinai PRIME
Currently, there are NaN active trials in "Mount Sinai PRIME".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Mount Sinai PRIME,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mount Sinai PRIME, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".